The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Clinical Implications of Basic Research
PreviousPrevious
Volume 342:651-653 March 2, 2000 Number 9
NextNext

A Nuclear Receptor to Prevent Colon Cancer

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
It is not often that two seemingly separate lines of investigation converge to yield both a new insight into the pathogenesis of a disease and possibilities for clinical applications. Such is the case with an article by He et al., who report that the chemopreventive effects of nonsteroidal antiinflammatory drugs on colorectal cancer involve the interaction of the adenomatous polyposis coli (APC) tumor-suppressor pathway and the nuclear hormone receptor peroxisome-proliferator–activated receptor {delta} (PPAR{delta}).1 Their study establishes a molecular link between the genetics of colonic neoplasia and the mechanism by which nonsteroidal antiinflammatory drugs can prevent colorectal cancer. This effect of . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.